I am a senior scientist with over 13 years of expertise in pharmacology, preclinical assessment, and pharmaceutical drug development. My specialization includes planning, managing, and monitoring nonclinical studies, with a proven track record of advancing over eight drugs from preclinical to clinical stages. I offer expertise in lead candidate selection, assay development, and executing complex in vitro and in vivo pharmacological studies.

My technical skills encompass precision medicine, tumor biomarkers, CRISPR-Cas9 gene editing, and epigenetics. I have successfully developed and optimized high-throughput assays, designed innovative therapeutic molecules, and collaborated with multidisciplinary teams on regulatory submissions, leading to FDA approvals. Additionally, I provide support in strategy development, scientific communication, and stakeholder collaborations for seamless transitions from preclinical to clinical phases.

I have extensive experience working with CROs, securing research funding, and publishing high-impact scientific papers. I am available to support projects requiring advanced technical methodologies, regulatory insights, or specialized knowledge in oncology, molecular biology, and drug discovery.